Found 403 matching trials
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a single arm, open-label, dose escalation clinical study to evaluat...
Show More Learn More & Join Trial
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis EARLY_PHASE1 A single-center, open-label dose-escalation design to evaluate the safety a...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Study on TIL for the Treatment of r/r Gynecologic Tumors PHASE1 This study is to investigate the safety and efficacy of tumor infiltrating ...
Show More Location
Shanghai Tenth People's Hospital
Learn More & Join Trial
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) PHASE1 This is a Phase 1/2, multi-center, open-label study evaluating the safety a...
Show More Location
University of California, Los Angeles (UCLA) Medical Center
Learn More & Join Trial
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors PHASE1 This is a single-center, single-arm ,open-label ,dose escalation and dose e...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia PHASE1 This is a a phase 1, open label study to assess the safety and efficacy of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma PHASE1 The purpose of this clinical trial is to learn if allogeneic cord blood-der...
Show More Location
Xi'an No.3 Hospital
Learn More & Join Trial
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. PHASE1 This study is an open-label, exploratory, prospective clinical trial with d...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies PHASE1 This is a single-center, open-label, single-arm study to evaluate the prima...
Show More Location
Union Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 The study is a Phase I/II, single-arm, open-label clinical trial, and its p...
Show More Location
The Third Xiangya Hospital of Central South University
Learn More & Join Trial